Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
OTHER
×
tislelizumab
×
Clear all
Filters
3
NCT06303583
2024-03-12
CRIS
Zhejiang Cancer Hospital
Phase 1/2
Enrolling by invitation
30 enrolled